Potential neuroprotective effects of acamprosate

George F. Koob; Barbara J. Mason; Philippe De Witte; John Littleton; George R. Siggins

doi:10.1111/j.1530-0277.2002.tb02578.x

Potential neuroprotective effects of acamprosate

George F. Koob
, Barbara J. Mason
, Philippe De Witte
, John Littleton
, George R. Siggins

Psychology

Producción científica: Article › revisión exhaustiva

52 Citas (Scopus)

Resumen

This article represents the proceedings of a symposium at the 2001 RSA Meeting in Montreal, Canada. The organizers were Barbara J. Mason and George F. Koob. Anita M. Goodman served as chair. The presentations were (1) Acamprosate inhibits alcohol withdrawal-induced neurotoxicity in organotypic hippocampal cultures, by John Littleton; (2) Acamprosate alteration of NMDA receptor-dependent synaptic transmission and synaptic plasticity, by George R. Siggins; (3) Acamprosate and glutamate during ethanol withdrawal, by Philippe De Witte; (4) Clinical evidence of protective CNS effects of acamprosate in alcohol-dependent individuals, by Barbara J. Mason.

Idioma original	English
Páginas (desde-hasta)	586-592
Número de páginas	7
Publicación	Alcoholism: Clinical and Experimental Research
Volumen	26
N.º	4
DOI	https://doi.org/10.1111/j.1530-0277.2002.tb02578.x
Estado	Published - 2002

ASJC Scopus subject areas

Medicine (miscellaneous)
Toxicology
Psychiatry and Mental health

ODS de las Naciones Unidas

Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

Acceder al documento

10.1111/j.1530-0277.2002.tb02578.x

Otros archivos y enlaces

Citar esto

@article{11638a3646554b128af05568345015eb,

title = "Potential neuroprotective effects of acamprosate",

abstract = "This article represents the proceedings of a symposium at the 2001 RSA Meeting in Montreal, Canada. The organizers were Barbara J. Mason and George F. Koob. Anita M. Goodman served as chair. The presentations were (1) Acamprosate inhibits alcohol withdrawal-induced neurotoxicity in organotypic hippocampal cultures, by John Littleton; (2) Acamprosate alteration of NMDA receptor-dependent synaptic transmission and synaptic plasticity, by George R. Siggins; (3) Acamprosate and glutamate during ethanol withdrawal, by Philippe De Witte; (4) Clinical evidence of protective CNS effects of acamprosate in alcohol-dependent individuals, by Barbara J. Mason.",

keywords = "Acamprosate, Alcoholism, Glutamate, Neuroprotective",

author = "Koob, \{George F.\} and Mason, \{Barbara J.\} and \{De Witte\}, Philippe and John Littleton and Siggins, \{George R.\}",

year = "2002",

doi = "10.1111/j.1530-0277.2002.tb02578.x",

language = "English",

volume = "26",

pages = "586--592",

number = "4",

}

TY - JOUR

T1 - Potential neuroprotective effects of acamprosate

AU - Koob, George F.

AU - Mason, Barbara J.

AU - De Witte, Philippe

AU - Littleton, John

AU - Siggins, George R.

PY - 2002

Y1 - 2002

N2 - This article represents the proceedings of a symposium at the 2001 RSA Meeting in Montreal, Canada. The organizers were Barbara J. Mason and George F. Koob. Anita M. Goodman served as chair. The presentations were (1) Acamprosate inhibits alcohol withdrawal-induced neurotoxicity in organotypic hippocampal cultures, by John Littleton; (2) Acamprosate alteration of NMDA receptor-dependent synaptic transmission and synaptic plasticity, by George R. Siggins; (3) Acamprosate and glutamate during ethanol withdrawal, by Philippe De Witte; (4) Clinical evidence of protective CNS effects of acamprosate in alcohol-dependent individuals, by Barbara J. Mason.

AB - This article represents the proceedings of a symposium at the 2001 RSA Meeting in Montreal, Canada. The organizers were Barbara J. Mason and George F. Koob. Anita M. Goodman served as chair. The presentations were (1) Acamprosate inhibits alcohol withdrawal-induced neurotoxicity in organotypic hippocampal cultures, by John Littleton; (2) Acamprosate alteration of NMDA receptor-dependent synaptic transmission and synaptic plasticity, by George R. Siggins; (3) Acamprosate and glutamate during ethanol withdrawal, by Philippe De Witte; (4) Clinical evidence of protective CNS effects of acamprosate in alcohol-dependent individuals, by Barbara J. Mason.

KW - Acamprosate

KW - Alcoholism

KW - Glutamate

KW - Neuroprotective

UR - https://www.scopus.com/pages/publications/0036124030

UR - https://www.scopus.com/pages/publications/0036124030#tab=citedBy

U2 - 10.1111/j.1530-0277.2002.tb02578.x

DO - 10.1111/j.1530-0277.2002.tb02578.x

M3 - Article

C2 - 11981137

AN - SCOPUS:0036124030

SN - 0145-6008

VL - 26

SP - 586

EP - 592

JO - Alcoholism: Clinical and Experimental Research

JF - Alcoholism: Clinical and Experimental Research

IS - 4

ER -

Potential neuroprotective effects of acamprosate

Resumen

ASJC Scopus subject areas

ODS de las Naciones Unidas

Acceder al documento

Otros archivos y enlaces

Huella

Citar esto